Index

Index

Choose a letter from the index to search the Code Of Practice

Key
  • links to Clauses in the Code
  • links to supplementary information to a Clause in the Code
  • links to a paragraph in the Constitution and Procedure
A
  • abbreviated advertisements
    5.1
  • ABPI (the Association of the British Pharmaceutical Industry)
  • absolute risk, reference to
    7.2
    7.2
    1.1
  • advance notification of new products
    3.1
    3.1
  • adverse reactions
  • advertising to the public
    1.1
    26.1
    26.1
  • advice on Code
  • advice on personal medical matters
    26.4
    26.4
  • all-embracing claims
    7.10
    7.10
  • amendments to Code and Constitution and Procedure
  • amount of advertising in journals
    6.0
    6.0
  • animal data, use of
    7.2
    7.2
  • annual report
    20
  • appeals against Panel rulings
    • appeals by complainants
      7.4
      7.3
    • appeals by respondent companies
      7.3
      7.5
    • appearance before Appeal Board
      4.6
    • withdrawal of appeals
      15.1
  • Appeal Board
    • see Code of Practice Appeal Board
      • applicability of codes
        1.1
        1.1
      • approval of promotional material – see certification
  • artwork, illustrations, graphs and tables
    7.8
    • abbreviated advertisements
      5.4
      5.5
      5.6
      5.7
      5.8
      5.9
      5.4
    • references to sources when taken from published studies
      7.8
      7.8
    • see also si to 7.2 on use of statistical information
      7.2
  • audio-visual material and interactive data systems etc
  • audit of company’s procedures
    10.4
    11.3
    12.2
  • automated calling systems
    9.9
B
C
  • carers, hospitality to
    27.2
    27.2
  • case preparation manager
    2.1
    5.1
    5.2
    5.6
  • case reports
    13.1
  • central platform for disclosure of transfers of value
    24.1
    24.1
  • certification
    • general
      14
    • audio and audio-visual material etc
      14.1
      14.1
    • content of certificate
      14.5
    • digital material
      14.1
      14.1
    • educational material relating to diseases 
    • Internet
      14.1
      14.1
    • joint ventures and co-promotion
      14.1
      14.1
    • joint working material
      14.3
      20
      20
    • meetings held outside UK
      14.2
      14.2
    • non-promotional material relating to the provision of medical and educational goods and services
      14.3
    • notification of signatories
      14.4
    • patient organisation material
      14.3
    • patient support programme material
      14.3
    • presentations by UK speakers at meetings held outside the UK
      14.2
      14.2
    • preservation of certificates
      14.6
      14.6
    • promotional aids
      14.1
      14.1
    • promotional material
      14.1
    • promotional material at international conferences in UK
      3.0
      3.0
    • signatories, qualifications and experience of
      14.1
      14.1
  • children in advertisements
    7.8
    7.8
  • clinical and scientific opinion
    • current views of authors
      10.4
      10.4
    • disparaging clinical and scientific opinion
      8.2
    • emerging opinion
      7.2
      7.2
  • clinical assessments
    7.5
    12.2
    7.5
  • clinical trials, disclosure of details
    13.1
    13.1
  • Codes of Practice for Advertising Over-the-Counter Medicines of the PAGB
  • Code of Practice Appeal Board
    • Constitution and Procedure
      3.1
      4.1
    • co-option to
      4.2
    • independent members to be in a majority
      4.2
    • membership
      3.2
    • power to:
    • reports from Code of Practice Panel
      4.1
      8.1
    • reports to ABPI Board
      12.1
    • reports to, consideration of
      11.1
    • rulings
      10.1
  • Code of Practice levy
    16.1
  • Code of Practice Panel
    • Constitution and Procedure
      2.1
    • membership
      2.1
    • power to suspend advertising on complaints from Medicines and Healthcare products Regulatory Agency
      9.2
    • power to suspend material/activities pending an appeal
      7.1
    • reports to Appeal Board
      8.1
    • rulings
      7.1
  • Commission on Human Medicines, Medicines and Healthcare products Regulatory Agency and licensing authority, references to
    9.5
    9.5
  • comparisons
  • Competition and Markets Authority
    • consultation with on Code
      19.2
  • competitions & quizzes
    18.1
    18.1
  • complaints procedure
    • complaints arising from media criticism
      6.1
    • complaints from Medicines and Healthcare products Regulatory Agency
      6.1
    • confidentiality of complainants
    • Constitution and Procedure
      5.1
      13.1
    • dealing with complaints
    • making complaints 
      • general
      • by pharmaceutical companies
        5.3
    • withdrawal of complaints
      15.1
  • conciliation between companies
    18.2
  • conferences
  • confidence in the industry
    13.7
  • consultants
  • continuing professional development meetings and
  • contracts with institutions etc
    21
  • co-promotion
    14.1
    14.1
  • corporate advertising, examination of
    14.3
    14.3
  • cost comparisons
    7.2
    7.2
  • cost of promotional material
    9.7
  • criticism in media
    6.1
  • current views of authors
    10.4
    10.4
D
  • data on file, provision of
    7.7
  • date of prescribing information
    4.2
    4.2
  • date of promotional material
    4.8
  • delivery of items by representatives
    15.3
    15.3
  • devices
    4.1
    4.1
  • disclosure of transfers of value
    1.10
    24
    1.10
  • discounts
  • discredit to the industry
    13.7
  • disease awareness campaigns
    26.2
    26.2
    • Disease Awareness Campaigns Guidelines
      26.2
      26.2
  • disguised promotion
    12
  • disparaging references
    8
  • distribution of promotional material
    11
  • doctors, use of names and photographs
    9.3
    9.3
  • donations
  • DVDs for health professessionals
    18.1
    18.1
  • dynamic content for websites
    14.1
    14.1
E
  • economic evaluation of medicines
    7.2
    7.2
  • educational goods and services
    19
  • educational or informational material
    9.7
  • EFPIA Code of Practice on Relationships between the Pharmaceutical Industry and Patient Organisations see introduction to Code & page 60
  • EFPIA Code on Disclosure of Transfers of Value by Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations & page 60
  • EFPIA Code on the Promotion of Prescription Medicines to, and Interactions with, Healthcare Professionals see introduction to Code & page 60
  • electronic data communications
    9.9
  • email
    9.9
    15.0
    15.0
    9.9
  • emoticons
    9.2
    9.2
  • employee responsible for ensuring compliance with Code
    1.12
    1.12
  • employees, current and prospective, information for
    26.2
    26.2
  • envelopes
    9.8
  • Europe
    24.1
    24.1
  • European Directive see introduction to Code & page 60 
  • exaggerated or all-embracing claims
    7.10
    7.10
  • examination of material
    14.3
    14.3
  • examinations for representatives
    16.3
    16.4
    16.3
    16.4
  • exemptions to promotion
    1.2
    • It does not include exhibitions and exhibition panels, prescribing 
  • experience programmes
    12.2
  • exposed mailings
    9.8
F
G
H
  • hanging comparisons
    7.2
    7.2
  • health professional
    • definition
      1.4
    • use of name and photograph
      9.3
  • health professionals’ code of conduct and page 60
    15.3
    18.1
    22.1
    15.3
    18.1
    22.1
  • health professions, criticism of
    8.2
  • health technology assessments
    1.2
    26.2
    1.2
    26.2
  • healthcare organisation
    1.9
    1.9
  • healthy volunteer studies, use of data from
    7.2
    7.2
  • high standards, maintenance of
  • hospitality
    22
  • Human Medicines Regulations & Page 60
I
  • information requirements
    4.1
    4.1
  • IFPMA Code of Practice & Page 60
  • illustrations
    • see artwork, illustrations, graphs and tables 
  • inducements
    18.1
    13.7
  • information to the public
    26
    28
  • informational or educational materials
    9.7
  • inserts in journals
  • interactive data systems
    • see audio-visual material and interactive data  systems etc
  • international conferences, symposia and meetings see meetings
  • Internet
    • general
      28
    • abbreviated advertisements not permitted
      5.2
    • access to promotional material by public
      28.1
      28.1
    • certification
      14.1
      14.1
    • journals
      28.4
    • prescribing information requirements
      4.6
  • in-vitro data
    7.2
    7.2
  • items delivered by representatives
    15.3
    15.3
  • items for patients
    18.2
    18.2
J
  • joint ventures & co-promotion
    14.1
    14.1
  • joint working with the NHS
    1.1
    20
    1.1
    20
  • journal advertising
    • advertising in international journals
      1.1
      1.1
    • number of pages of
      6.3
    • specific requirements
      4.7
      6.0
    • see also abbreviated advertisements in professional 
    • publications
      5.2
      5.2
K
L
  • labelling of: 
  • legislation page 60
  • levy
  • licensing authority, references to
    9.5
  • limitations on journal advertising
    6.0
    6.0
  • links to prescribing information
    4.4
    4.4
  • loans, long term or permanent
    18.1
    18.1
  • loose inserts in journals
    6.2
M
  • mailings
  • margins see trade practices 
  • market extension
    1.1
    1.1
  • market research
    12.2
    12.2
    • disclosure of payments
      23.1
      23.3
      23.1
      23.3
    • guidelines The Legal & Ethical Guidelines for 
    • Healthcare Market Research & page 60
      12.2
      12.2
    • revealing company responsible
      9.10
      9.10
  • market share claims
    7
  • marketing authorization
    3.0
    3.0
  • meals
    22.2
    22.2
  • media
    • complaints arising from
      6.1
    • relations with
      26
  • medical and educational goods and services
    19
  • medicine, definition
    1.3
  • medicines
  • Medicines and Healthcare products Regulatory Agency
    • case reports
      13.5
    • complaints from
      9.1
    • consultation with on:
      • appointment of independent Appeal Board
      • members
        3.1
      • Code
        19.2
    • Disease Awareness Campaigns Guidelines & page 60
      26.2
      26.2
    • MHRA Drug Safety Update
      9.5
      9.5
    • references to
      9.5
      9.5
    • submission of: 
      • briefing material to
        15.9
      • certificates to
        14.6
      • names of signatories for promotional material to
        14.4
    • The Blue Guide Advertising and Promotion of Medicines in the UK & page 60
      1.1
      28.1
      28.4
      28.5
      1.1
      28.1
      28.4
      28.5
    • yellow card scheme
      4.1
      5.6
  • meetings
    22
    • attendance by administrative staff
      22.1
      22.1
    • certification of meetings held outside the UK
      14.2
      14.2
    • continuing professional development (CPD) 
    • exhibitions and exhibition panels, prescribing 
      • information requirements
        4.1
        4.1
    • held outside the UK
      22.1
      22.1
    • hospitality, provision of
      22.1
      22.1
    • involving travel outside the UK
      22.1
      22.1
    • organised by affiliates
      22.1
      22.1
    • payment of room rental
      22.3
      22.3
    • payment of travelling and accommodation expenses 
      22
    • prohibition on inducements and payments for interviews
      15.3
      18.1
      18.1
    • promotion at international meetings
      1.1
      3.0
      22.1
      1.1
      3.0
      22.1
    • reports on meetings
      10.3
      22.4
      22.4
    • sponsorship of attendance at meetings, disclosure of
      22.5
      22.5
    • sponsorship of meetings, disclosure of
      22.4
      22.4
    • subsistence, provision of
      22.1
      22.1
    • venue, suitability of
      22.1
      22.1
  • memory sticks for health professionals
    18.1
    18.1
  • MHRA Drug Safety Update
    9.5
    9.5
N
  • naked or partially naked people, use of in advertising
    9.2
    9.2
  • new medicines
    • advance notification of
      3.1
      3.1
    • format, size or cost of promotional material for
      9.7
      9.7
    • limitations on mailings
      11.2
      11.2
  • new use of the word
    7.11
  • non-interventional studies of marketed medicines
    13.2
    13.3
    13.2
    13.3
  • non-proprietary name, size and position
    4.3
    5.5
  • notebooks, pens and pencils
    18.3
    18.3
  • Nursing & Midwifery Council
O
  • offence, causing
    9.2
  • official documents, reproduction of
    9.6
  • ordinary course sales and purchase of medicines
    1.10
    1.10
  • other relevant decision makers
    1.5
  • outcome agreements
    18.1
  • over-the-counter medicines 
P
  • package deals
    18.1
    18.1
  • package leaflets
    1.2
  • Panel - see Code of Practice Panel
  • patient access schemes
    18.1
    18.1
  • patient information leaflets
  • patient organisations
  • patient safety
    13.7
  • patient support items
    18.2
    18.2
  • payments for interviews
    15.3
    18.1
    15.3
    18.1
  • pecuniary advantage, offer or provision of
    18.1
    18.1
  • personal benefits
    18.1
    19.1
    19.2
    18.1
    19.1
    19.2
  • pharmacovigilance
    13.0
    16
    13.0
  • PMCPA guidance notes & Page 60
  • post-authorization studies
    12.2
    13.0
  • postcards, use of
    9.8
  • posted medicines
    17.8
  • post-marketing surveillance studies
    12.2
    13.0
  • potency per weight claims
    7.2
    7.2
  • pre-printed private prescription forms
    9.2
    9.2
  • prescribing information 
  • prescription forms
    • pre-printed private prescription forms
      9.2
      9.2
      • reproduction of official documents
        9.6
  • Prescription Medicines Code of Practice Authority
    • annual report
      20
    • material to be supplied to Authority 
      • authority of Director to require material
        1.4
      • copies of certificates
        14.6
      • examination status of representatives
        16.4
      • material required for scrutiny
        17.1
      • medical representatives’ briefing material
        15.9
      • names of signatories
        14.4
    • scrutiny
      17.1
    • structure and responsibilities
      1.1
  • press conferences and press announcements
    26.2
    26.2
  • pre-vetting
  • price comparisons
    7.2
    7.2
  • price lists
    1.2
  • prices (see trade prices)
  • private prescription forms, preprinted
    9.2
    9.2
  • prizes
    18.1
    18.1
  • professional publications
    5.2
    5.2
  • promotion
  • promotional aid 
  • provision of medicines and samples control and accountability
    17.9
    17.9
  • public assessment reports (European & UK)
  • public health campaigns
    26.2
    26.2
  • public relations activities
    26
    26.2
    26.2
    • responsibility for
      26.5
  • public, relations with 
Q
R
  • referee, independent
    5.2
    5.3
    7.2
    7.4
    7.5
    7.6
    5.1
  • references
    • prohibition in abbreviated advertisements
    • references to published studies
      7.6
      7.8
      7.6
      7.8
  • relative risk, reference to
    7.2
    7.2
  • remote detailing
    9.9
    9.9
  • replies to individual enquiries
    1.2
    1.2
  • reply paid cards
    9.8
    9.8
    • reply paid cards offering items to be delivered by 
    • see also samples, request forms
      17.3
      17.3
  • representatives 
  • reprints of articles, distribution of
    10.1
    10.1
  • reproduction of official documents
    9.6
  • risk/benefit profile
    7.10
    7.10
  • risk, relative and absolute
    7.2
    7.2
  • risk sharing agreements
    18.1
    18.1
  • room rental, payment
    22.3
    22.3
  • Royal College of Nursing 
    • case reports
      13.5
    • consultation with on:
      • appointment of independent Appeal Board 
      • member
        3.2
      • Code
        19.2
  • Royal Pharmaceutical Society 
    • case reports
      13.5
    • consultation with on:
      • appointment of independent Appeal Board 
      • member
        3.2
      • Code
        19.2
  • rulings by:
S
  • safe use of the word
    7.9
    7.9
  • samples
    17.0
  • sanctions
  • scientific services
    25
    • to approve and supervise non-interventional studies 
      25.2
    • to compile and collate all information received 
      25.1
  • scope of the Code
    1
  • scrutiny
    17.1
  • Serious Fraud Office 
    • consultation with on Code
      19.2
  • sexual imagery, use of
    9.2
    9.2
  • side-effects - see adverse reactions
  • signatories
    14
  • size of promotional material 
    • abbreviated advertisements
      5.3
    • extremes of format
      9.7
      9.7
  • sponsorship of material and meetings, disclosure of
    9.10
    22.4
    9.10
    22.4
  • sponsorship of meeting attendance, disclosure of
    22.5
    22.5
  • starter packs
    17.0
    17.0
  • statistical information, use of
    7.2
    7.2
    • see also si to 7.8 on artwork, illustrations, graphs and tables
      7.8
      7.8
  • subsistence, provision of
    22.1
    22.2
    22.1
    22.2
  • substantiation of information, claims and comparisons
    7.4
    7.5
    7.4
    7.5
  • suitability and taste
    9.2
    9.2
  • summaries of product characteristics
  • superlatives
    7.10
    7.10
  • suspension of advertising on complaints from Medicines and Healthcare products Regulatory Agency 
    9.2
  • suspension of material/activities required by Panel pending appeal
    7.2
    7.3
  • switch and therapy review programmes
    19.1
    19.1
  • symposia - see meetings
T
  • tables - see artwork, illustrations, graphs and tables 
  • taste in advertising
    9.2
    9.2
  • teaser advertising
    9.2
    9.2
  • telemessages
    9.9
    15.0
    15.0
  • telephone and text messages
    9.9
    15.0
    15.0
  • terms of trade - see trade practices
  • text messages
    9.9
    15.0
    15.0
  • textbooks, provision of
    18.1
    18.1
  • the use of the word
    7.10
    7.10
  • therapy review programmes
    19.1
  • timing under complaints procedure 
    • general
      14
    • appeals
      7.3
    • commenting on appeal by complainant
      7.4
    • commenting on appeal by respondent
      7.5
    • extensions
      7.1
      14
    • payment of administrative charge
    • providing an undertaking on rulings by
    • responding to complaint
      5.4
    • suspension of material/activities required by Panel pending appeal
      7.1
      7.3
  • titration packs
    17.0
    17.0
  • trade practices, prices, discounts, margins, etc under ‘It does not include’​​
    1.2
    18.1
    18.1
  • training
  • transfers of value
    24
  • travelling expenses
    22
  • two page journal advertisements
    6.1
U
  • unauthorized medicines and unauthorized indications - see also unlicensed medicines
    3.0
    3.0
  • undertakings by companies ruled in breach
    7.1
    7.3
    10.2
  • undertakings, breach of
    29
    13.7
  • unique use of the word
    7.10
    7.10
  • unlicensed medicines, price lists of
    1.2
    1.2
V
  • volume of promotional material
    11.2
    11.2
  • voluntary admissions by pharmaceutical companies 
    5.6
    16.4
W
  • WHO Ethical Criteria for Medicinal Drug Promotion see introduction to Code and page 60 
  • withdrawal of complaints and appeals
    15.1
  • wraparounds on journals
    6.2
    6.2
  • wrappers
    9.8
Y
Index

Choose a letter from the index to search the Code Of Practice

Key
  • links to Clauses in the Code
  • links to supplementary information to a Clause in the Code
  • links to a paragraph in the Constitution and Procedure

Interactive 2016 Code
Download Code of Practice 2016
image description
Changes to the 2015 Code and Constitution and Procedure